XML 21 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenues $ 92,380 $ 71,296
Cost of revenues [1] 53,107 37,184
Gross profit 39,273 34,112
Operating expenses:    
Sales and marketing [1] 19,884 15,805
Research and development [1] 24,958 17,657
General and administrative [1] 19,110 13,860
Acquisition related costs (1,967) 2,718
Amortization of acquired intangibles 4,491 1,215
Total operating expenses 66,476 51,255
Loss from operations (27,203) (17,143)
Other income (expense):    
Interest and other income 456 807
Interest and other expense (6,921) (3,014)
Total other income (expense), net (6,465) (2,207)
Loss before income taxes (33,668) (19,350)
Benefit from (provision for) income taxes (440) 39
Net loss (34,108) (19,311)
Other comprehensive loss:    
Unrealized gain (loss) on available-for-sale investments (122) 113
Foreign currency translation adjustment (55) 12
Comprehensive loss $ (34,285) $ (19,186)
Net loss per common share, basic and diluted (usd per share) $ (0.70) $ (0.44)
Weighted average common shares outstanding:    
Basic and diluted (in shares) 48,581 43,773
[1]
Includes stock-based compensation expenses as follows:
 
 
Three Months Ended March 31,
 
 
2020
 
2019
Cost of revenues
 
$
3,408

 
$
1,548

Sales and marketing
 
2,754

 
1,806

Research and development
 
3,770

 
2,012

General and administrative
 
4,604

 
3,530

Total stock-based compensation expenses
 
$
14,536

 
$
8,896